Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MTHFR polymorphisms and ovarian cancer risk: a meta-analysis.

Molecular biology reports - 1 Nov 2012

Liu Lu, Liao Shao-Guang, Wang Ya-Jie

Abstract excerpt

The C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase (MTHFR) have been reported to alter the risk of ovarian cancer. However, the results are still inconclusive. For better understanding of the effect of these two polymorphisms on ovarian cancer risk, a meta-analysis was performed. An extensive search was performed to identify all case-control studies investigating such association. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Ethnicity
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Ovarian Neoplasms

Share to Polymorphism, Genetic

Share to Risk Factors

Share to White People

Source

Identifiers

PMID: 22810649
DOI: 10.1007/s11033-012-1852-0

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MTHFR polymorphisms and ovarian cancer risk: a meta-analysis.PMID 22810649Read ↗

MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis.Semantic proximity Read ↗

The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.Semantic proximity Read ↗

Association between MTHFR gene polymorphism and the risk of ovarian cancer: a meta-analysis of the literature.Semantic proximity Read ↗

MTHFR A1298C polymorphism and ovarian cancer risk: a meta-analysis.Semantic proximity Read ↗

Folate intake and MTHFR polymorphism C677T is not associated with ovarian cancer risk: evidence from the meta-analysis.Semantic proximity Read ↗

ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.Semantic proximity Read ↗

Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene Ala222Val and susceptibility to ovary cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Folate intake and methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers for ovarian cancer risk.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase C677T polymorphism and colorectal cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Lack of association between MTHFD1 G401A polymorphism and ovarian cancer susceptibility.Semantic proximity Read ↗

Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.